Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

Nature Medicine

Volumn 6, Issue 4, 2000, Pages 464-469

  Wekerle, Thomas ^a,c   Kurtz, Josef ^a   Ito, Hiroshi ^a   Ronquillo, Joseph V ^a   Dong, Victor ^b   Zhao, Guiling ^a   Shaffer, Juanita ^a   Sayegh, Mohamed H ^b   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BONE MARROW TRANSPLANTATION; CD40 LIGAND; FEMALE; IMMUNE TOLERANCE; IMMUNOCONJUGATES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TRANSPLANTATION CHIMERA; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 0034071426     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/74731     Document Type: Article

References (35)

1. Ildstad, S.T. & Sachs, D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307, 168-170 (1984).
2. Sharabi, Y. & Sachs, D.H. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J. Exp. Med. 169, 493-502 (1989).
3. Nomoto, K. et al. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-αβ monoclonal antibody, low dose irradiation, and donor bone marrow transfusion. Transplantation 59, 395-401 (1995).
4. Kawai, T. et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomologous monkeys. Transplantation 59, 256-262 (1995).
5. Sykes, M., Szot, G.L., Swenson, K. & Pearson, D.A. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nature Med. 3, 783-787 (1997).
6. De Vries-van der Zwan, A., Besseling, A.C., De Waal, L.P. & Boog, C.J.P. Specific tolerance induction and transplantation: a single-day protocol. Blood 89, 2596-2601 (1997).
7. Wekerle, T. et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J. Exp. Med. 187, 2037-2044 (1998).
8. Sharabi, Y., Aksentijevich, I., Sundt III, T.M., Sachs, D.H. & Sykes, M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J. Exp. Med. 172, 195-202 (1990).
9. Mayumi, H. & Good, R.A. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. J. Exp. Med. 169, 213-238 (1989).
10. Colson, Y.L. et al. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J. Immunol. 157, 2820-2829 (1996).
11. Storb, R. et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89, 3048-3054 (1997).
12. Stewart, F.M., Crittenden, R.B., Lowry, P.A., Pearson-White, S. & Quesenberry, P.J. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81, 2566-2571 (1993).
13. Sykes, M., Szot, G.L., Swenson, K., Pearson, D.A. & Wekerle, T. Separate regulation of peripheral hematopoietic and thymic engraftment. Exp. Hematol. 26, 457-465 (1998).
14. Li, H. et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J. Immunol. 156, 380-388 (1996).
15. Wang, B.-Y., Cherry, El-Badri, N.S. & Good, R.A. Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation. Proc. Natl. Acad. Sci. USA 94, 12065-12069 (1999).
16. Messner, R.P. The potential of bone marrow stem cell transplantation in the treatment of autoimmune disease. J. Rheumatol. 24, 819-821 (1997).
17. Krivit, W., Peters, C. & Shapiro, E.G. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenaleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr. Opin. Neurol. 12, 167-176 (1999).
18. Krivit, W. & Shapiro, E.G. in Bone Marrow Transplantation, eds: Forman, S.J., Blume, K.G., Thomas, E.D. 883-893 (Blackwell Scientific Publications, Cambridge, Massachusetts, 1994).
19. Down, J.D. & Ploemacher, R.E. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp. Hematol. 21, 913-921 (1993).
20. Bachar-Lustig, E., Rachamin, N., Li, H.-W., Lan, F. & Reisner, Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nature Med. 1, 1268-1273 (1995).
21. Larsen, C.P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
22. Kirk, A. et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med. 5, 685-693 (1999)
23. Kirk, A.D. et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94, 8789-8794 (1997).
24. Sayegh, M.H. & Turka, L.A. The role of T cell costimulatory activation pathways in transplant rejection. N. Engl. J. Med. 338, 1813-1821 (1998).
25. Elwood, E.T. et al. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 65, 1422-1428 (1998).
26. Trambley, J. et al. Asialo CM1 (+) CD8 (+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104, 1715-1722 (1999).
27. Abrams, J.R. et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103, 1243-1252 (1999).
28. Tomonari, K. & Fairchild, S. The genetic basis of negative selection of Tcrb-V11 + T cells. Immunogenetics 33, 157-162 (1991).
29. Dyson, P.J., Knight, A.M., Fairchild, S., Simpson, E. & Tomonari, K. Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature 349, 531-532 (1991).
30. Acha-Orbea, H. & Palmer, E. Mls- a retrovirus exploits the immune system. Immunol. Today 12, 356-361 (1991).
31. Bill, J., Kanagawa, O., Woodland, D. & Palmer, E. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of Vβ11 bearing T cells. J. Exp. Med. 169, 1405-1419 (1989).
32. Brocker, T., Riedinger, M. & Karjalainen, K. Targeted expression of major histocompatibility complex (MHC) demonstrates that dendritic cells can induce negative but not positive selection in vivo. J. Exp. Med. 185, 541-550 (1997).
33. Sykes, M. Chimerism and central tolerance. Curr. Opin. Immunol. 8, 694-703 (1996).
34. Tomita, Y., Khan, A. & Sykes, M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J. Immunol. 153, 1087-1098 (1994).
35. Colson, Y.L., Lange, J., Fowler, K. & Ildstad, S.T. Mechanism of cotolerance in nonlethally conditioned mixed chimeras: negative selection of the Vβ T-cells receptor repertoire by both host and donor bone marrow-derived cells. Blood 88, 4601-4610 (1997).